ID   ULK1_HUMAN              Reviewed;        1050 AA.
AC   O75385; Q9UQ28;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Serine/threonine-protein kinase ULK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Autophagy-related protein 1 homolog;
DE            Short=ATG1;
DE            Short=hATG1;
DE   AltName: Full=Unc-51-like kinase 1;
GN   Name=ULK1; Synonyms=KIAA0722;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-816.
RX   PubMed=9693035; DOI=10.1006/geno.1998.5340;
RA   Kuroyanagi H., Yan J., Seki N., Yamanouchi Y., Suzuki Y., Takano T.,
RA   Muramatsu M., Shirasawa T.;
RT   "Human ULK1, a novel serine/threonine kinase related to UNC-51 kinase
RT   of Caenorhabditis elegans: cDNA cloning, expression, and chromosomal
RT   assignment.";
RL   Genomics 51:76-85(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-816.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   INTERACTION WITH GABARAP AND GABARAPL2, AND REGION.
RX   PubMed=11146101; DOI=10.1016/S0169-328X(00)00218-7;
RA   Okazaki N., Yan J., Yuasa S., Ueno T., Kominami E., Masuho Y.,
RA   Koga H., Muramatsu M.-A.;
RT   "Interaction of the Unc-51-like kinase and microtubule-associated
RT   protein light chain 3 related proteins in the brain: possible role of
RT   vesicular transport in axonal elongation.";
RL   Brain Res. Mol. Brain Res. 85:1-12(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477 AND SER-479, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; THR-456 AND
RP   SER-556, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   SUBUNIT, AND COMPLEX FORMATION WITH ATG13; ATG101 AND RB1CC1.
RX   PubMed=19287211; DOI=10.4161/auto.5.5.8249;
RA   Mercer C.A., Kaliappan A., Dennis P.B.;
RT   "A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and
RT   is essential for macroautophagy.";
RL   Autophagy 5:649-662(2009).
RN   [10]
RP   SUBUNIT.
RX   PubMed=19597335; DOI=10.4161/auto.5.7.9296;
RA   Hosokawa N., Sasaki T., Iemura S.I., Natsume T., Hara T.,
RA   Mizushima N.;
RT   "Atg101, a novel mammalian autophagy protein interacting with Atg13.";
RL   Autophagy 5:973-979(2009).
RN   [11]
RP   SUBUNIT, AND INTERACTION WITH RPTOR AND TORC1 COMPLEX.
RX   PubMed=19211835; DOI=10.1091/mbc.E08-12-1248;
RA   Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y.,
RA   Iemura S., Natsume T., Takehana K., Yamada N., Guan J.L., Oshiro N.,
RA   Mizushima N.;
RT   "Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200
RT   complex required for autophagy.";
RL   Mol. Biol. Cell 20:1981-1991(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH ATG13.
RX   PubMed=18936157; DOI=10.1128/MCB.01082-08;
RA   Chan E.Y.W., Longatti A., McKnight N.C., Tooze S.A.;
RT   "Kinase-inactivated ULK proteins inhibit autophagy via their conserved
RT   C-terminal domains using an Atg13-independent mechanism.";
RL   Mol. Cell. Biol. 29:157-171(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450 AND SER-638, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; THR-456 AND
RP   SER-638, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF AMPK.
RX   PubMed=21460634; DOI=10.4161/auto.7.7.15451;
RA   Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M.,
RA   Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B.;
RT   "Ulk1-mediated phosphorylation of AMPK constitutes a negative
RT   regulatory feedback loop.";
RL   Autophagy 7:696-706(2011).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH RPTOR.
RX   PubMed=21795849; DOI=10.4161/auto.7.10.16660;
RA   Jung C.H., Seo M., Otto N.M., Kim D.H.;
RT   "ULK1 inhibits the kinase activity of mTORC1 and cell proliferation.";
RL   Autophagy 7:1212-1221(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; SER-469; SER-556
RP   AND SER-638, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION BY AMPK.
RX   PubMed=21205641; DOI=10.1126/science.1196371;
RA   Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S., Kohnz R.A.,
RA   Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M.,
RA   Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J.;
RT   "Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase
RT   connects energy sensing to mitophagy.";
RL   Science 331:456-461(2011).
RN   [20]
RP   INTERACTION WITH FEZ1.
RX   PubMed=22354037; DOI=10.1038/emboj.2012.36;
RA   McKnight N.C., Jefferies H.B., Alemu E.A., Saunders R.E., Howell M.,
RA   Johansen T., Tooze S.A.;
RT   "Genome-wide siRNA screen reveals amino acid starvation-induced
RT   autophagy requires SCOC and WAC.";
RL   EMBO J. 31:1931-1946(2012).
RN   [21]
RP   INTERACTION WITH TBC1D14.
RX   PubMed=22613832; DOI=10.1083/jcb.201111079;
RA   Longatti A., Lamb C.A., Razi M., Yoshimura S., Barr F.A., Tooze S.A.;
RT   "TBC1D14 regulates autophagosome formation via Rab11- and ULK1-
RT   positive recycling endosomes.";
RL   J. Cell Biol. 197:659-675(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-450; SER-467;
RP   SER-469; SER-477; SER-479; SER-556; SER-638; SER-758 AND SER-775, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   FUNCTION, INTERACTION WITH SESN2 AND SQSTM1, AND REGION.
RX   PubMed=25040165; DOI=10.1111/febs.12905;
RA   Ro S.H., Semple I.A., Park H., Park H., Park H.W., Kim M., Kim J.S.,
RA   Lee J.H.;
RT   "Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of
RT   p62/sequestosome-1.";
RL   FEBS J. 281:3816-3827(2014).
RN   [24]
RP   INTERACTION WITH TRIM5.
RX   PubMed=25127057; DOI=10.1016/j.devcel.2014.06.013;
RA   Mandell M.A., Jain A., Arko-Mensah J., Chauhan S., Kimura T.,
RA   Dinkins C., Silvestri G., Munch J., Kirchhoff F., Simonsen A., Wei Y.,
RA   Levine B., Johansen T., Deretic V.;
RT   "TRIM proteins regulate autophagy and can target autophagic substrates
RT   by direct recognition.";
RL   Dev. Cell 30:394-409(2014).
RN   [25]
RP   INTERACTION WITH BECN1; IRF3; MEFV AND TRIM21.
RX   PubMed=26347139; DOI=10.1083/jcb.201503023;
RA   Kimura T., Jain A., Choi S.W., Mandell M.A., Schroder K., Johansen T.,
RA   Deretic V.;
RT   "TRIM-mediated precision autophagy targets cytoplasmic regulators of
RT   innate immunity.";
RL   J. Cell Biol. 210:973-989(2015).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-290; LEU-298; LEU-478; MET-503;
RP   LEU-665; LEU-714 AND CYS-784.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in autophagy in
CC       response to starvation. Acts upstream of phosphatidylinositol 3-
CC       kinase PIK3C3 to regulate the formation of autophagophores, the
CC       precursors of autophagosomes. Part of regulatory feedback loops in
CC       autophagy: acts both as a downstream effector and negative
CC       regulator of mammalian target of rapamycin complex 1 (mTORC1) via
CC       interaction with RPTOR. Activated via phosphorylation by AMPK and
CC       also acts as a regulator of AMPK by mediating phosphorylation of
CC       AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively
CC       regulate AMPK activity. May phosphorylate ATG13/KIAA0652 and
CC       RPTOR; however such data need additional evidences. Plays a role
CC       early in neuronal differentiation and is required for granule cell
CC       axon formation. May also phosphorylate SESN2 and SQSTM1 to
CC       regulate autophagy (PubMed:25040165).
CC       {ECO:0000269|PubMed:18936157, ECO:0000269|PubMed:21460634,
CC       ECO:0000269|PubMed:21795849, ECO:0000269|PubMed:25040165}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with GABARAP and GABARAPL2. Interacts (via C-
CC       terminus) with ATG13. Part of a complex consisting of ATG13,
CC       ATG101, ULK1 and RB1CC1. Associates with the mammalian target of
CC       rapamycin complex 1 (mTORC1) through an interaction with RPTOR;
CC       the association depends on nutrient conditions and is reduced
CC       during starvation. Interacts with FEZ1; SCOC interferes with FEZ1-
CC       binding. Interacts with TBC1D14. Interacts (phosphorylated form)
CC       with TRIM5 (PubMed:25127057). When phosphorylated at Ser-317,
CC       interacts with MEFV and BECN1 simultaneously. Interacts with
CC       TRIM21 and IRF3, in the presence of TRIM21 (PubMed:26347139).
CC       Interacts with SESN2 (PubMed:25040165). Interacts with SQSTM1
CC       (PubMed:25040165). {ECO:0000269|PubMed:11146101,
CC       ECO:0000269|PubMed:18936157, ECO:0000269|PubMed:19211835,
CC       ECO:0000269|PubMed:19287211, ECO:0000269|PubMed:19597335,
CC       ECO:0000269|PubMed:21795849, ECO:0000269|PubMed:22354037,
CC       ECO:0000269|PubMed:22613832, ECO:0000269|PubMed:25040165,
CC       ECO:0000269|PubMed:25127057, ECO:0000269|PubMed:26347139}.
CC   -!- INTERACTION:
CC       O75143:ATG13; NbExp=4; IntAct=EBI-908831, EBI-2798775;
CC       Q9H0R8:GABARAPL1; NbExp=2; IntAct=EBI-908831, EBI-746969;
CC       P60520:GABARAPL2; NbExp=3; IntAct=EBI-908831, EBI-720116;
CC       Q9GZQ8:MAP1LC3B; NbExp=2; IntAct=EBI-908831, EBI-373144;
CC       Q9BXW4:MAP1LC3C; NbExp=2; IntAct=EBI-908831, EBI-2603996;
CC       Q8TDY2:RB1CC1; NbExp=7; IntAct=EBI-908831, EBI-1047793;
CC       Q9P2M4:TBC1D14; NbExp=4; IntAct=EBI-908831, EBI-2797718;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}.
CC       Preautophagosomal structure {ECO:0000250}. Note=Under starvation
CC       conditions, is localized to puncate structures primarily
CC       representing the isolation membrane that sequesters a portion of
CC       the cytoplasm resulting in the formation of an autophagosome.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Detected in the
CC       following adult tissues: skeletal muscle, heart, pancreas, brain,
CC       placenta, liver, kidney, and lung.
CC   -!- PTM: Autophosphorylated. Phosphorylated under nutrient-rich
CC       conditions; dephosphorylated during starvation or following
CC       treatment with rapamycin. Under nutrient sufficiency,
CC       phosphorylated by MTOR/mTOR, disrupting the interaction with AMPK
CC       and preventing activation of ULK1 (By similarity). In response to
CC       nutrient limitation, phosphorylated and activated by AMPK, leading
CC       to activate autophagy. {ECO:0000250, ECO:0000269|PubMed:21205641}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. APG1/unc-51/ULK1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34442.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF045458; AAC32326.1; -; mRNA.
DR   EMBL; AB018265; BAA34442.2; ALT_INIT; mRNA.
DR   EMBL; AC131009; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9274.1; -.
DR   RefSeq; NP_003556.1; NM_003565.2.
DR   UniGene; Hs.47061; -.
DR   PDB; 4WNO; X-ray; 1.56 A; A=1-283.
DR   PDB; 4WNP; X-ray; 1.88 A; A/B/C/D=1-283.
DR   PDB; 5CI7; X-ray; 1.74 A; A=1-283.
DR   PDBsum; 4WNO; -.
DR   PDBsum; 4WNP; -.
DR   PDBsum; 5CI7; -.
DR   ProteinModelPortal; O75385; -.
DR   SMR; O75385; -.
DR   BioGrid; 113996; 47.
DR   DIP; DIP-35196N; -.
DR   IntAct; O75385; 29.
DR   MINT; MINT-1892187; -.
DR   STRING; 9606.ENSP00000324560; -.
DR   BindingDB; O75385; -.
DR   ChEMBL; CHEMBL6006; -.
DR   GuidetoPHARMACOLOGY; 2271; -.
DR   iPTMnet; O75385; -.
DR   PhosphoSitePlus; O75385; -.
DR   SwissPalm; O75385; -.
DR   BioMuta; ULK1; -.
DR   EPD; O75385; -.
DR   MaxQB; O75385; -.
DR   PaxDb; O75385; -.
DR   PeptideAtlas; O75385; -.
DR   PRIDE; O75385; -.
DR   DNASU; 8408; -.
DR   Ensembl; ENST00000321867; ENSP00000324560; ENSG00000177169.
DR   GeneID; 8408; -.
DR   KEGG; hsa:8408; -.
DR   UCSC; uc001uje.4; human.
DR   CTD; 8408; -.
DR   DisGeNET; 8408; -.
DR   GeneCards; ULK1; -.
DR   HGNC; HGNC:12558; ULK1.
DR   HPA; HPA063990; -.
DR   MIM; 603168; gene.
DR   neXtProt; NX_O75385; -.
DR   OpenTargets; ENSG00000177169; -.
DR   PharmGKB; PA37198; -.
DR   eggNOG; KOG0595; Eukaryota.
DR   eggNOG; ENOG410XR01; LUCA.
DR   GeneTree; ENSGT00870000136410; -.
DR   HOGENOM; HOG000044146; -.
DR   HOVERGEN; HBG000342; -.
DR   InParanoid; O75385; -.
DR   KO; K21357; -.
DR   OMA; DTDDFVM; -.
DR   OrthoDB; EOG091G14RD; -.
DR   PhylomeDB; O75385; -.
DR   TreeFam; TF324551; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-8854214; TBC/RABGAPs.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   SignaLink; O75385; -.
DR   SIGNOR; O75385; -.
DR   ChiTaRS; ULK1; human.
DR   GeneWiki; ULK1; -.
DR   GenomeRNAi; 8408; -.
DR   PRO; PR:O75385; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177169; -.
DR   CleanEx; HS_ULK1; -.
DR   Genevisible; O75385; HS.
DR   GO; GO:1990316; C:ATG1/ULK1 kinase complex; IPI:UniProtKB.
DR   GO; GO:0005776; C:autophagosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0097635; C:extrinsic component of autophagosome membrane; IDA:UniProtKB.
DR   GO; GO:0097629; C:extrinsic component of omegasome membrane; IDA:UniProtKB.
DR   GO; GO:0097632; C:extrinsic component of pre-autophagosomal structure membrane; IDA:UniProtKB.
DR   GO; GO:0034045; C:pre-autophagosomal structure membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:BHF-UCL.
DR   GO; GO:0006914; P:autophagy; IDA:UniProtKB.
DR   GO; GO:0048675; P:axon extension; IBA:GO_Central.
DR   GO; GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB.
DR   GO; GO:0016236; P:macroautophagy; IMP:BHF-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0031333; P:negative regulation of protein complex assembly; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031175; P:neuron projection development; IMP:UniProtKB.
DR   GO; GO:0031102; P:neuron projection regeneration; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:HGNC.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0008104; P:protein localization; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; NAS:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016237; Ser/Thr_kin_STPK_Ulk-1/2.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR022708; Ser/Thr_kinase_C.
DR   Pfam; PF12063; DUF3543; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000580; Ser/Thr_PK_STPK_ULK-1/2; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Autophagy; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1050       Serine/threonine-protein kinase ULK1.
FT                                /FTId=PRO_0000086780.
FT   DOMAIN       16    278       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      22     30       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      287    416       Interaction with GABARAP and GABARAPL2.
FT                                {ECO:0000269|PubMed:11146101}.
FT   REGION      828   1050       C-terminal domain; mediates interaction
FT                                with SESN2.
FT                                {ECO:0000269|PubMed:25040165}.
FT   COMPBIAS    297    310       Poly-Ser.
FT   ACT_SITE    138    138       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      46     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     317    317       Phosphoserine; by AMPK. {ECO:0000250}.
FT   MOD_RES     403    403       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     450    450       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     456    456       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     469    469       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     477    477       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     479    479       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70405}.
FT   MOD_RES     556    556       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     575    575       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O70405}.
FT   MOD_RES     636    636       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O70405}.
FT   MOD_RES     638    638       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     639    639       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70405}.
FT   MOD_RES     758    758       Phosphoserine; by MTOR.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000305|PubMed:21205641}.
FT   MOD_RES     775    775       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     290    290       V -> M (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs370624303).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041274.
FT   VARIANT     298    298       S -> L (in dbSNP:rs56364352).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041275.
FT   VARIANT     478    478       P -> L (in dbSNP:rs12827141).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041276.
FT   VARIANT     503    503       T -> M (in dbSNP:rs55824543).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041277.
FT   VARIANT     665    665       S -> L (in dbSNP:rs55815560).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041278.
FT   VARIANT     714    714       P -> L (in dbSNP:rs11546871).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041279.
FT   VARIANT     784    784       S -> C (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041280.
FT   VARIANT     816    816       T -> A (in dbSNP:rs11609348).
FT                                {ECO:0000269|PubMed:9693035,
FT                                ECO:0000269|PubMed:9872452}.
FT                                /FTId=VAR_054892.
FT   STRAND        9     11       {ECO:0000244|PDB:4WNO}.
FT   STRAND       14     24       {ECO:0000244|PDB:4WNO}.
FT   STRAND       29     37       {ECO:0000244|PDB:4WNO}.
FT   STRAND       42     47       {ECO:0000244|PDB:4WNO}.
FT   HELIX        50     52       {ECO:0000244|PDB:4WNO}.
FT   HELIX        53     67       {ECO:0000244|PDB:4WNO}.
FT   STRAND       78     83       {ECO:0000244|PDB:4WNO}.
FT   STRAND       88     93       {ECO:0000244|PDB:4WNO}.
FT   HELIX       100    106       {ECO:0000244|PDB:4WNO}.
FT   HELIX       112    132       {ECO:0000244|PDB:4WNO}.
FT   HELIX       141    143       {ECO:0000244|PDB:4WNO}.
FT   STRAND      144    147       {ECO:0000244|PDB:4WNO}.
FT   HELIX       151    153       {ECO:0000244|PDB:4WNP}.
FT   HELIX       156    158       {ECO:0000244|PDB:4WNO}.
FT   STRAND      160    163       {ECO:0000244|PDB:4WNO}.
FT   TURN        185    187       {ECO:0000244|PDB:4WNO}.
FT   HELIX       190    193       {ECO:0000244|PDB:4WNO}.
FT   HELIX       201    216       {ECO:0000244|PDB:4WNO}.
FT   HELIX       226    235       {ECO:0000244|PDB:4WNO}.
FT   HELIX       249    258       {ECO:0000244|PDB:4WNO}.
FT   TURN        263    265       {ECO:0000244|PDB:4WNO}.
FT   HELIX       269    273       {ECO:0000244|PDB:4WNO}.
FT   HELIX       276    278       {ECO:0000244|PDB:4WNO}.
SQ   SEQUENCE   1050 AA;  112631 MW;  AED9BD5139F2DB92 CRC64;
     MEPGRGGTET VGKFEFSRKD LIGHGAFAVV FKGRHREKHD LEVAVKCINK KNLAKSQTLL
     GKEIKILKEL KHENIVALYD FQEMANSVYL VMEYCNGGDL ADYLHAMRTL SEDTIRLFLQ
     QIAGAMRLLH SKGIIHRDLK PQNILLSNPA GRRANPNSIR VKIADFGFAR YLQSNMMAAT
     LCGSPMYMAP EVIMSQHYDG KADLWSIGTI VYQCLTGKAP FQASSPQDLR LFYEKNKTLV
     PTIPRETSAP LRQLLLALLQ RNHKDRMDFD EFFHHPFLDA SPSVRKSPPV PVPSYPSSGS
     GSSSSSSSTS HLASPPSLGE MQQLQKTLAS PADTAGFLHS SRDSGGSKDS SCDTDDFVMV
     PAQFPGDLVA EAPSAKPPPD SLMCSGSSLV ASAGLESHGR TPSPSPPCSS SPSPSGRAGP
     FSSSRCGASV PIPVPTQVQN YQRIERNLQS PTQFQTPRSS AIRRSGSTSP LGFARASPSP
     PAHAEHGGVL ARKMSLGGGR PYTPSPQVGT IPERPGWSGT PSPQGAEMRG GRSPRPGSSA
     PEHSPRTSGL GCRLHSAPNL SDLHVVRPKL PKPPTDPLGA VFSPPQASPP QPSHGLQSCR
     NLRGSPKLPD FLQRNPLPPI LGSPTKAVPS FDFPKTPSSQ NLLALLARQG VVMTPPRNRT
     LPDLSEVGPF HGQPLGPGLR PGEDPKGPFG RSFSTSRLTD LLLKAAFGTQ APDPGSTESL
     QEKPMEIAPS AGFGGSLHPG ARAGGTSSPS PVVFTVGSPP SGSTPPQGPR TRMFSAGPTG
     SASSSARHLV PGPCSEAPAP ELPAPGHGCS FADPITANLE GAVTFEAPDL PEETLMEQEH
     TEILRGLRFT LLFVQHVLEI AALKGSASEA AGGPEYQLQE SVVADQISLL SREWGFAEQL
     VLYLKVAELL SSGLQSAIDQ IRAGKLCLSS TVKQVVRRLN ELYKASVVSC QGLSLRLQRF
     FLDKQRLLDR IHSITAERLI FSHAVQMVQS AALDEMFQHR EGCVPRYHKA LLLLEGLQHM
     LSDQADIENV TKCKLCIERR LSALLTGICA
//
